Medical Education Library

A supplement to Skin & Allergy News.
This supplement is based on a symposium held on July 25, 2003, in Chicago, and supported by an educational grant from Johnson & Johnson Consumer Products Company.

•TOPICS/FACULTY/FACULTY DISCLOSURES
 

To view the supplement, click the image above.

Stratum Corneum Integrity is the Key to "Sensitive Skin"
James J. Leyden, MD
Professor Emeritus of Dermatology
University of Pennsylvania
Philadelphia, PA
Dr. Leyden has received grant/research support from Johnson & Johnson and Ortho. He is also a consultant to and on the Speaker's Bureau of Ortho.

Cosmeceuticals: A New Category of Skin Care Agents
Leslie S. Baumann, MD
Chief, Division of Cosmetic Dermatology
University of Miami
Miami, FL
Dr. Baumann has received grant/research support from Allergan, Inc., Elan, Galderma, Inamed, and Ligand Pharmaceuticals Incorporated.

Ancient Skin Remedies Come of Age for Today's Health-Conscious Consumers
Jeanine B. Downie, MD
Director
Image Dermatology
Montclair, NJ
Dr. Downie is a consultant/scientific advisor to Allergan, Bobbie Brown, Galderma, Johnson & Johnson, and Skin Salon Gold.

Several Active Naturals Aid in the Prevention of Photoaging
Zoe D. Draelos, MD
Clinical Associate Professor
Wake Forest School of Medicine
Winston-Salem, N.C.
Dr. Draelos has nothing to disclose.

Copyright © 2006 Elsevier Inc.

A supplement to Skin & Allergy News.
This supplement is based on a symposium held on July 25, 2003, in Chicago, and supported by an educational grant from Johnson & Johnson Consumer Products Company.

•TOPICS/FACULTY/FACULTY DISCLOSURES
 

To view the supplement, click the image above.

Stratum Corneum Integrity is the Key to "Sensitive Skin"
James J. Leyden, MD
Professor Emeritus of Dermatology
University of Pennsylvania
Philadelphia, PA
Dr. Leyden has received grant/research support from Johnson & Johnson and Ortho. He is also a consultant to and on the Speaker's Bureau of Ortho.

Cosmeceuticals: A New Category of Skin Care Agents
Leslie S. Baumann, MD
Chief, Division of Cosmetic Dermatology
University of Miami
Miami, FL
Dr. Baumann has received grant/research support from Allergan, Inc., Elan, Galderma, Inamed, and Ligand Pharmaceuticals Incorporated.

Ancient Skin Remedies Come of Age for Today's Health-Conscious Consumers
Jeanine B. Downie, MD
Director
Image Dermatology
Montclair, NJ
Dr. Downie is a consultant/scientific advisor to Allergan, Bobbie Brown, Galderma, Johnson & Johnson, and Skin Salon Gold.

Several Active Naturals Aid in the Prevention of Photoaging
Zoe D. Draelos, MD
Clinical Associate Professor
Wake Forest School of Medicine
Winston-Salem, N.C.
Dr. Draelos has nothing to disclose.

Copyright © 2006 Elsevier Inc.

A supplement to Skin & Allergy News.
This supplement is based on a symposium held on July 25, 2003, in Chicago, and supported by an educational grant from Johnson & Johnson Consumer Products Company.

•TOPICS/FACULTY/FACULTY DISCLOSURES
 

To view the supplement, click the image above.

Stratum Corneum Integrity is the Key to "Sensitive Skin"
James J. Leyden, MD
Professor Emeritus of Dermatology
University of Pennsylvania
Philadelphia, PA
Dr. Leyden has received grant/research support from Johnson & Johnson and Ortho. He is also a consultant to and on the Speaker's Bureau of Ortho.

Cosmeceuticals: A New Category of Skin Care Agents
Leslie S. Baumann, MD
Chief, Division of Cosmetic Dermatology
University of Miami
Miami, FL
Dr. Baumann has received grant/research support from Allergan, Inc., Elan, Galderma, Inamed, and Ligand Pharmaceuticals Incorporated.

Ancient Skin Remedies Come of Age for Today's Health-Conscious Consumers
Jeanine B. Downie, MD
Director
Image Dermatology
Montclair, NJ
Dr. Downie is a consultant/scientific advisor to Allergan, Bobbie Brown, Galderma, Johnson & Johnson, and Skin Salon Gold.

Several Active Naturals Aid in the Prevention of Photoaging
Zoe D. Draelos, MD
Clinical Associate Professor
Wake Forest School of Medicine
Winston-Salem, N.C.
Dr. Draelos has nothing to disclose.

Copyright © 2006 Elsevier Inc.

A supplement to Skin & Allergy News.
This educational supplement was supported by Johnson & Johnson Consumer Products Company.

•Guest Editor/Disclosure Statement
•Topic Highlights
 

To view the supplement, click the image above.

Leslie Baumann, MD
Professor of Dermatology
Chief, Division of Cosmetic Dermatology
University of Miami
Miami, Fla.
Dr. Baumann has received funding for clinical research from Avon Products, Inc., Galderma Laboratories, L.P., Johnson & Johnson Consumer Companies, Inc., and Stiefel Laboratories, Inc. She is also a speaker for Aveeno, L'Oreal, and Philosophy. Dr. Baumann is on the editorial advisory board of Skin & Allergy News.

Topic Highlights

• Introduction: Applying Nature to Dermatology Practice
• Rosemary
• Polypodium Leucotomos
• Propolis
• Oatmeal
• Olive Oil
• Dexpanthenol
• Grape Seed Extract
• Lavender
• Chamomile
• Soy and Its Isoflavones
• Vitamin A, Retinol, and Retinoids
• Vitamin E
• Green Tea
• Tea Tree Oil

Copyright © 2006 Elsevier Inc.

A supplement to Skin & Allergy News.
This educational supplement was supported by Johnson & Johnson Consumer Products Company.

•Guest Editor/Disclosure Statement
•Topic Highlights
 

To view the supplement, click the image above.

Leslie Baumann, MD
Professor of Dermatology
Chief, Division of Cosmetic Dermatology
University of Miami
Miami, Fla.
Dr. Baumann has received funding for clinical research from Avon Products, Inc., Galderma Laboratories, L.P., Johnson & Johnson Consumer Companies, Inc., and Stiefel Laboratories, Inc. She is also a speaker for Aveeno, L'Oreal, and Philosophy. Dr. Baumann is on the editorial advisory board of Skin & Allergy News.

Topic Highlights

• Introduction: Applying Nature to Dermatology Practice
• Rosemary
• Polypodium Leucotomos
• Propolis
• Oatmeal
• Olive Oil
• Dexpanthenol
• Grape Seed Extract
• Lavender
• Chamomile
• Soy and Its Isoflavones
• Vitamin A, Retinol, and Retinoids
• Vitamin E
• Green Tea
• Tea Tree Oil

Copyright © 2006 Elsevier Inc.

A supplement to Skin & Allergy News.
This educational supplement was supported by Johnson & Johnson Consumer Products Company.

•Guest Editor/Disclosure Statement
•Topic Highlights
 

To view the supplement, click the image above.

Leslie Baumann, MD
Professor of Dermatology
Chief, Division of Cosmetic Dermatology
University of Miami
Miami, Fla.
Dr. Baumann has received funding for clinical research from Avon Products, Inc., Galderma Laboratories, L.P., Johnson & Johnson Consumer Companies, Inc., and Stiefel Laboratories, Inc. She is also a speaker for Aveeno, L'Oreal, and Philosophy. Dr. Baumann is on the editorial advisory board of Skin & Allergy News.

Topic Highlights

• Introduction: Applying Nature to Dermatology Practice
• Rosemary
• Polypodium Leucotomos
• Propolis
• Oatmeal
• Olive Oil
• Dexpanthenol
• Grape Seed Extract
• Lavender
• Chamomile
• Soy and Its Isoflavones
• Vitamin A, Retinol, and Retinoids
• Vitamin E
• Green Tea
• Tea Tree Oil

Copyright © 2006 Elsevier Inc.

Proceedings of a Clinical Roundtable
A supplement to Skin & Allergy News
Supported by Chester Valley Pharmaceuticals.
The articles in this supplement are based on a faculty clinical roundtable discussion. It was produced in affiliation with Skin Disease Education Foundation's 30th Annual Hawaii Dermatology Seminar, a medical education program held February 11-18, 2006, in Kauai, Hawaii.

•Topics
•Faculty/Faculty Disclosure Statement
 

To view the supplement, click the image above.

• Introduction: The Clinical Landscape of Atopic Dermatitis
• Recent Developments in the Management of Atopic Dermatitis
• Quality-of-Life Issues
• Infection in Atopic Dermatitis
• Conventional Treatment Options: Corticosteroids, Calcineurin Inhibitors
• Safety Issues
• New Nonsteroidal Option

Faculty/Faculty Disclosure Statement

Lawrence F. Eichenfield, MD, Chair
Professor of Pediatrics and Medicine (Dermatology)
University of California, San Diego, School of Medicine
Chief, Pediatric and Adolescent Dermatology
Medical Director of Research
Children's Hospital and Health Center
San Diego
Dr. Eichenfield has received funding for a clinical study from Sinclair Pharma PLC.

Sarah L. Chamlin, MD
Assistant Professor of Pediatrics and Dermatology
Children's Memorial Hospital, Chicago
Northwestern University, Feinberg School of Medicine
Chicago
Dr. Chamlin is a consultant to Astellas Pharma Inc.

Sheila Fallon Friedlander, MD
Director, Fellowship Training Program
Pediatric and Adolescent Dermatology
Children's Hospital and Health Center, San Diego
Clinical Professor of Pediatrics and Medicine (Dermatology)
University of California, San Diego, School of Medicine
Dr. Friedlander is a consultant to Astellas, Connetics Corporation, GlaxoSmithKline, and Novartis AG.

Wm. Philip Werschler, MD, FAAD, FAACS
Assistant Clinical Professor in Medicine/Dermatology
University of Washington
Seattle
Dr. Werschler has nothing to disclose.

Copyright © 2006 Elsevier Inc.

Proceedings of a Clinical Roundtable
A supplement to Skin & Allergy News
Supported by Chester Valley Pharmaceuticals.
The articles in this supplement are based on a faculty clinical roundtable discussion. It was produced in affiliation with Skin Disease Education Foundation's 30th Annual Hawaii Dermatology Seminar, a medical education program held February 11-18, 2006, in Kauai, Hawaii.

•Topics
•Faculty/Faculty Disclosure Statement
 

To view the supplement, click the image above.

• Introduction: The Clinical Landscape of Atopic Dermatitis
• Recent Developments in the Management of Atopic Dermatitis
• Quality-of-Life Issues
• Infection in Atopic Dermatitis
• Conventional Treatment Options: Corticosteroids, Calcineurin Inhibitors
• Safety Issues
• New Nonsteroidal Option

Faculty/Faculty Disclosure Statement

Lawrence F. Eichenfield, MD, Chair
Professor of Pediatrics and Medicine (Dermatology)
University of California, San Diego, School of Medicine
Chief, Pediatric and Adolescent Dermatology
Medical Director of Research
Children's Hospital and Health Center
San Diego
Dr. Eichenfield has received funding for a clinical study from Sinclair Pharma PLC.

Sarah L. Chamlin, MD
Assistant Professor of Pediatrics and Dermatology
Children's Memorial Hospital, Chicago
Northwestern University, Feinberg School of Medicine
Chicago
Dr. Chamlin is a consultant to Astellas Pharma Inc.

Sheila Fallon Friedlander, MD
Director, Fellowship Training Program
Pediatric and Adolescent Dermatology
Children's Hospital and Health Center, San Diego
Clinical Professor of Pediatrics and Medicine (Dermatology)
University of California, San Diego, School of Medicine
Dr. Friedlander is a consultant to Astellas, Connetics Corporation, GlaxoSmithKline, and Novartis AG.

Wm. Philip Werschler, MD, FAAD, FAACS
Assistant Clinical Professor in Medicine/Dermatology
University of Washington
Seattle
Dr. Werschler has nothing to disclose.

Copyright © 2006 Elsevier Inc.

Proceedings of a Clinical Roundtable
A supplement to Skin & Allergy News
Supported by Chester Valley Pharmaceuticals.
The articles in this supplement are based on a faculty clinical roundtable discussion. It was produced in affiliation with Skin Disease Education Foundation's 30th Annual Hawaii Dermatology Seminar, a medical education program held February 11-18, 2006, in Kauai, Hawaii.

•Topics
•Faculty/Faculty Disclosure Statement
 

To view the supplement, click the image above.

• Introduction: The Clinical Landscape of Atopic Dermatitis
• Recent Developments in the Management of Atopic Dermatitis
• Quality-of-Life Issues
• Infection in Atopic Dermatitis
• Conventional Treatment Options: Corticosteroids, Calcineurin Inhibitors
• Safety Issues
• New Nonsteroidal Option

Faculty/Faculty Disclosure Statement

Lawrence F. Eichenfield, MD, Chair
Professor of Pediatrics and Medicine (Dermatology)
University of California, San Diego, School of Medicine
Chief, Pediatric and Adolescent Dermatology
Medical Director of Research
Children's Hospital and Health Center
San Diego
Dr. Eichenfield has received funding for a clinical study from Sinclair Pharma PLC.

Sarah L. Chamlin, MD
Assistant Professor of Pediatrics and Dermatology
Children's Memorial Hospital, Chicago
Northwestern University, Feinberg School of Medicine
Chicago
Dr. Chamlin is a consultant to Astellas Pharma Inc.

Sheila Fallon Friedlander, MD
Director, Fellowship Training Program
Pediatric and Adolescent Dermatology
Children's Hospital and Health Center, San Diego
Clinical Professor of Pediatrics and Medicine (Dermatology)
University of California, San Diego, School of Medicine
Dr. Friedlander is a consultant to Astellas, Connetics Corporation, GlaxoSmithKline, and Novartis AG.

Wm. Philip Werschler, MD, FAAD, FAACS
Assistant Clinical Professor in Medicine/Dermatology
University of Washington
Seattle
Dr. Werschler has nothing to disclose.

Copyright © 2006 Elsevier Inc.

A supplement to Skin & Allergy News.
Supported by Stiefel.
The articles in this supplement are based on presentations made during Skin Disease Education Foundation's 30th Annual Hawaii Dermatology Seminar, held February 13, 2006, in Kauai, Hawaii.

•Topics
•Faculty/Faculty Disclosure Statement
•Target Audience

To view the supplement, click the image above.

• Introduction
• The Importance of Vehicle and Skin Barrier Function in Acne Vulgaris
• Combination Therapy Considerations in Acne Vulgaris
• Evolving Therapy in Atopic Dermatitis
• Nonsteroidal Treatment of Atopic Dermatitis

Faculty/Faculty Disclosure Statement

Emil A. Tanghetti, MD, Chair
Clinical Professor of Dermatology
University of California, Davis School of Medicine
Medical Director
Center for Dermatology and Laser Surgery
Sacramento
Dr. Tanghetti has received funding for clinical grants from and is a consultant to Allergan Inc., and Stiefel Laboratories, Inc.

Leon Kircik, MD
Clinical Associate Professor
Division of Dermatology
Indiana University
Indianapolis
Medical Director
Physicians Skin Care, PLLC
Louisville, Ky.
Dr. Kircik has received funding as an investigator, consultant, advisor, or speaker from Abbott Laboratories, Allergan Inc., Amgen, Inc., Astellas Pharma US, Inc., Berlex Inc., Biogen Idec Inc., Centocor, Inc., Connetics Corporation, Dermik Laboratories, Dowpharma, Ferndale Laboratories, Inc., Galderma Laboratories, L.P., Genentech Inc., GlaxoSmithKline, HealthPoint Ltd., Medicis Pharmaceutical Corporation, Novartis Pharmaceuticals Corporation, Nucryst Pharmaceutical Corporation, QLT Inc., SkinMedica, Stiefel Laboratories, Inc., 3M Pharmaceuticals, Valeant Pharmaceuticals International, and Warner-Chilcott, PLC. He has stated that he will reference the unlabeled/unapproved uses of the following drugs: clindamycin 1% benzoyl peroxide 5% gel (Duac Topical Gel) for acne.

Lawrence F. Eichenfield, MD
Professor of Pediatrics and Medicine (Dermatology)
University of California, San Diego, School of Medicine
Children's Hospital
San Diego
Dr. Eichenfield has received clinical grants from Astellas Pharma US, Inc., Connetics Corporation, Dermik Laboratories, Ferndale Laboratories, Inc., Galderma Laboratories, L.P., GlaxoSmithKline, Hill Dermacueticals, Inc., and Novartis Pharmaceuticals Corporation. He is also a consultant to Connetics and Novartis. He has stated that he will reference the unlabeled/unapproved uses of the following drugs: MimyX cream for atopic dermatitis, MAS063D (Atopiclair) for atopic dermatitis, and a probiotic, Lactobacillus fermentum, for atopic dermatitis.

James Turner, MD, PhD
Clinical Professor
Division of Dermatology
Department of Medicine
University of Tennessee
Memphis
Dr. Turner is a consultant to Stiefel Laboratories, Inc. He has stated that he will reference the unlabeled/unapproved uses of the following drugs: MimyX cream for atopic dermatitis and clindamycin 1% benzoyl peroxide 5% gel.

Target Audience

This activity is intended for healthcare professionals, including dermatologists and pediatricians, who are involved in the treatment of patients with acne vulgaris or atopic dermatitis.

Copyright © 2006 Elsevier Inc.

A supplement to Skin & Allergy News.
Supported by Stiefel.
The articles in this supplement are based on presentations made during Skin Disease Education Foundation's 30th Annual Hawaii Dermatology Seminar, held February 13, 2006, in Kauai, Hawaii.

•Topics
•Faculty/Faculty Disclosure Statement
•Target Audience

To view the supplement, click the image above.

• Introduction
• The Importance of Vehicle and Skin Barrier Function in Acne Vulgaris
• Combination Therapy Considerations in Acne Vulgaris
• Evolving Therapy in Atopic Dermatitis
• Nonsteroidal Treatment of Atopic Dermatitis

Faculty/Faculty Disclosure Statement

Emil A. Tanghetti, MD, Chair
Clinical Professor of Dermatology
University of California, Davis School of Medicine
Medical Director
Center for Dermatology and Laser Surgery
Sacramento
Dr. Tanghetti has received funding for clinical grants from and is a consultant to Allergan Inc., and Stiefel Laboratories, Inc.

Leon Kircik, MD
Clinical Associate Professor
Division of Dermatology
Indiana University
Indianapolis
Medical Director
Physicians Skin Care, PLLC
Louisville, Ky.
Dr. Kircik has received funding as an investigator, consultant, advisor, or speaker from Abbott Laboratories, Allergan Inc., Amgen, Inc., Astellas Pharma US, Inc., Berlex Inc., Biogen Idec Inc., Centocor, Inc., Connetics Corporation, Dermik Laboratories, Dowpharma, Ferndale Laboratories, Inc., Galderma Laboratories, L.P., Genentech Inc., GlaxoSmithKline, HealthPoint Ltd., Medicis Pharmaceutical Corporation, Novartis Pharmaceuticals Corporation, Nucryst Pharmaceutical Corporation, QLT Inc., SkinMedica, Stiefel Laboratories, Inc., 3M Pharmaceuticals, Valeant Pharmaceuticals International, and Warner-Chilcott, PLC. He has stated that he will reference the unlabeled/unapproved uses of the following drugs: clindamycin 1% benzoyl peroxide 5% gel (Duac Topical Gel) for acne.

Lawrence F. Eichenfield, MD
Professor of Pediatrics and Medicine (Dermatology)
University of California, San Diego, School of Medicine
Children's Hospital
San Diego
Dr. Eichenfield has received clinical grants from Astellas Pharma US, Inc., Connetics Corporation, Dermik Laboratories, Ferndale Laboratories, Inc., Galderma Laboratories, L.P., GlaxoSmithKline, Hill Dermacueticals, Inc., and Novartis Pharmaceuticals Corporation. He is also a consultant to Connetics and Novartis. He has stated that he will reference the unlabeled/unapproved uses of the following drugs: MimyX cream for atopic dermatitis, MAS063D (Atopiclair) for atopic dermatitis, and a probiotic, Lactobacillus fermentum, for atopic dermatitis.

James Turner, MD, PhD
Clinical Professor
Division of Dermatology
Department of Medicine
University of Tennessee
Memphis
Dr. Turner is a consultant to Stiefel Laboratories, Inc. He has stated that he will reference the unlabeled/unapproved uses of the following drugs: MimyX cream for atopic dermatitis and clindamycin 1% benzoyl peroxide 5% gel.

Target Audience

This activity is intended for healthcare professionals, including dermatologists and pediatricians, who are involved in the treatment of patients with acne vulgaris or atopic dermatitis.

Copyright © 2006 Elsevier Inc.

A supplement to Skin & Allergy News.
Supported by Stiefel.
The articles in this supplement are based on presentations made during Skin Disease Education Foundation's 30th Annual Hawaii Dermatology Seminar, held February 13, 2006, in Kauai, Hawaii.

•Topics
•Faculty/Faculty Disclosure Statement
•Target Audience

To view the supplement, click the image above.

• Introduction
• The Importance of Vehicle and Skin Barrier Function in Acne Vulgaris
• Combination Therapy Considerations in Acne Vulgaris
• Evolving Therapy in Atopic Dermatitis
• Nonsteroidal Treatment of Atopic Dermatitis

Faculty/Faculty Disclosure Statement

Emil A. Tanghetti, MD, Chair
Clinical Professor of Dermatology
University of California, Davis School of Medicine
Medical Director
Center for Dermatology and Laser Surgery
Sacramento
Dr. Tanghetti has received funding for clinical grants from and is a consultant to Allergan Inc., and Stiefel Laboratories, Inc.

Leon Kircik, MD
Clinical Associate Professor
Division of Dermatology
Indiana University
Indianapolis
Medical Director
Physicians Skin Care, PLLC
Louisville, Ky.
Dr. Kircik has received funding as an investigator, consultant, advisor, or speaker from Abbott Laboratories, Allergan Inc., Amgen, Inc., Astellas Pharma US, Inc., Berlex Inc., Biogen Idec Inc., Centocor, Inc., Connetics Corporation, Dermik Laboratories, Dowpharma, Ferndale Laboratories, Inc., Galderma Laboratories, L.P., Genentech Inc., GlaxoSmithKline, HealthPoint Ltd., Medicis Pharmaceutical Corporation, Novartis Pharmaceuticals Corporation, Nucryst Pharmaceutical Corporation, QLT Inc., SkinMedica, Stiefel Laboratories, Inc., 3M Pharmaceuticals, Valeant Pharmaceuticals International, and Warner-Chilcott, PLC. He has stated that he will reference the unlabeled/unapproved uses of the following drugs: clindamycin 1% benzoyl peroxide 5% gel (Duac Topical Gel) for acne.

Lawrence F. Eichenfield, MD
Professor of Pediatrics and Medicine (Dermatology)
University of California, San Diego, School of Medicine
Children's Hospital
San Diego
Dr. Eichenfield has received clinical grants from Astellas Pharma US, Inc., Connetics Corporation, Dermik Laboratories, Ferndale Laboratories, Inc., Galderma Laboratories, L.P., GlaxoSmithKline, Hill Dermacueticals, Inc., and Novartis Pharmaceuticals Corporation. He is also a consultant to Connetics and Novartis. He has stated that he will reference the unlabeled/unapproved uses of the following drugs: MimyX cream for atopic dermatitis, MAS063D (Atopiclair) for atopic dermatitis, and a probiotic, Lactobacillus fermentum, for atopic dermatitis.

James Turner, MD, PhD
Clinical Professor
Division of Dermatology
Department of Medicine
University of Tennessee
Memphis
Dr. Turner is a consultant to Stiefel Laboratories, Inc. He has stated that he will reference the unlabeled/unapproved uses of the following drugs: MimyX cream for atopic dermatitis and clindamycin 1% benzoyl peroxide 5% gel.

Target Audience

This activity is intended for healthcare professionals, including dermatologists and pediatricians, who are involved in the treatment of patients with acne vulgaris or atopic dermatitis.

Copyright © 2006 Elsevier Inc.

A supplement to Skin & Allergy News.
This supplement was produced in affiliation with the 30th Hawaii Dermatology Seminar and the Cosmetic Dermatology Seminar.

•Topic Highlights
•Guest Editors

To view the supplement, click the image above.

• New Options Spur Interest in Combination Treatment

• Preventive Skin Care Forms Basis for Battle Against Sun and Aging

• For Quick Results, Think Nonablative Resurfacing

• Plasma Energy Harnessed for Damaged, Aging Skin

• Horse Chestnut

• New Laser System Offers Another Skin Tx Option

• Maintaining Safety, Integrity of Botulinum Toxin A

Guest Editors

David J. Goldberg, MD, JD
Clinical Professor of Dermatology
Director, Laser Research and Mohs Surgery
Mount Sinai School of Medicine
Adjunct Professor of Law
Fordham Law School
New York, N.Y.
Director, Skin Laser & Surgery Specialists of New York/New Jersey
New York, N.Y.
Clinical Grants: Photo Therapeutics, Cynosure, Inc., Neocutis Swiss Technology, Inamed Corporation, Thermage, Inc., and Cutera Inc.; Consultant: BioForm Medical Inc., Lumenis Ltd., and Juva Medical Inc.

Christopher B. Zachary, FRCP
Chair and Clinical Professor
Department of Dermatology
Co-Director, Dermatologic Surgery and Laser Center
University of California at Irvine
Nothing to disclose.

Copyright © 2006 Elsevier Inc.

A supplement to Skin & Allergy News.
This supplement was produced in affiliation with the 30th Hawaii Dermatology Seminar and the Cosmetic Dermatology Seminar.

•Topic Highlights
•Guest Editors

To view the supplement, click the image above.

• New Options Spur Interest in Combination Treatment

• Preventive Skin Care Forms Basis for Battle Against Sun and Aging

• For Quick Results, Think Nonablative Resurfacing

• Plasma Energy Harnessed for Damaged, Aging Skin

• Horse Chestnut

• New Laser System Offers Another Skin Tx Option

• Maintaining Safety, Integrity of Botulinum Toxin A

Guest Editors

David J. Goldberg, MD, JD
Clinical Professor of Dermatology
Director, Laser Research and Mohs Surgery
Mount Sinai School of Medicine
Adjunct Professor of Law
Fordham Law School
New York, N.Y.
Director, Skin Laser & Surgery Specialists of New York/New Jersey
New York, N.Y.
Clinical Grants: Photo Therapeutics, Cynosure, Inc., Neocutis Swiss Technology, Inamed Corporation, Thermage, Inc., and Cutera Inc.; Consultant: BioForm Medical Inc., Lumenis Ltd., and Juva Medical Inc.

Christopher B. Zachary, FRCP
Chair and Clinical Professor
Department of Dermatology
Co-Director, Dermatologic Surgery and Laser Center
University of California at Irvine
Nothing to disclose.

Copyright © 2006 Elsevier Inc.

A supplement to Skin & Allergy News.
This supplement was produced in affiliation with the 30th Hawaii Dermatology Seminar and the Cosmetic Dermatology Seminar.

•Topic Highlights
•Guest Editors

To view the supplement, click the image above.

• New Options Spur Interest in Combination Treatment

• Preventive Skin Care Forms Basis for Battle Against Sun and Aging

• For Quick Results, Think Nonablative Resurfacing

• Plasma Energy Harnessed for Damaged, Aging Skin

• Horse Chestnut

• New Laser System Offers Another Skin Tx Option

• Maintaining Safety, Integrity of Botulinum Toxin A

Guest Editors

David J. Goldberg, MD, JD
Clinical Professor of Dermatology
Director, Laser Research and Mohs Surgery
Mount Sinai School of Medicine
Adjunct Professor of Law
Fordham Law School
New York, N.Y.
Director, Skin Laser & Surgery Specialists of New York/New Jersey
New York, N.Y.
Clinical Grants: Photo Therapeutics, Cynosure, Inc., Neocutis Swiss Technology, Inamed Corporation, Thermage, Inc., and Cutera Inc.; Consultant: BioForm Medical Inc., Lumenis Ltd., and Juva Medical Inc.

Christopher B. Zachary, FRCP
Chair and Clinical Professor
Department of Dermatology
Co-Director, Dermatologic Surgery and Laser Center
University of California at Irvine
Nothing to disclose.

Copyright © 2006 Elsevier Inc.

This educational supplement to Skin & Allergy News is supported by Neutrogena.
This supplement provides highlights of, and supplemental background information for, the roundtable panel discussion following the Stable Photoprotection Advisory Board Meeting, held October 28, 2005, in Atlanta, GA.

•Topic Highlights
•Faculty
•Target Audience

To view the supplement, click the image above.

Photoprotection and Our Evolving Understanding of the Effects of Ultraviolet Light

• Introduction

• The Effects of UVA/UVB Radiation

• Sunscreens: A Historical Perspective

• Testing Standards and Labeling Issues

• Public Health Concerns

• Developing the Optimal Sunscreen

• UVA-Specific Photoprotectants

Summary

Faculty

Program ChairmanDarrell S. Rigel, MD
Clinical Professor
Deparment of Dermatology
New York University Medical Center
New York, New York
Consultant/Funding for Clinical Grants: Neutrogena Corporation

Diane S. Berson, MD
Assistant Professor
Department of Dermatology
Weill Medical College
Cornell University
New York, New York

Assistant Clinical Professor
Department of Dermatology
New York University School of Medicine
New York, New York
Consultant: Neutrogena Corporation.
She does not have any stock interests, equity interests, or patent-licensing arrangements that could be considered a conflict of interest for this supplement.

Robert J. Ceilly, MD
Clinical Professor
Department of Dermatology
University of Iowa
Des Moines, Iowa
Consultant: OrthoNeutrogena.
He does not have any stock interests, equity interests, or patent-licensing arrangements that could be considered a conflict of interest for this supplement.

Curtis A. Cole, PhD
Senior Director of Technology
Johnson & Johnson Consumer Products Company
Skillman, New Jersey
He is an employee of, directs funding for clinical grants, and holds stock from Johnson & Johnson.

Zoe Diana Draelos, MD
Clinical Associate Professor
Department of Dermatology
Wake Forest University School of Medicine
Winston-Salem, North Carolina
Consultant: Neutrogena Corporation.
She does not have any stock interests, equity interests, or patent-licensing arrangements that could be considered a conflict of interest for this supplement.

Target Audience

This supplement has been developed for dermatologists and other health care professionals who are concerned with issues involving photoprotection and who recommend sunscreen products to their patients.

Copyright © 2006 Elsevier Inc.

This educational supplement to Skin & Allergy News is supported by Neutrogena.
This supplement provides highlights of, and supplemental background information for, the roundtable panel discussion following the Stable Photoprotection Advisory Board Meeting, held October 28, 2005, in Atlanta, GA.

•Topic Highlights
•Faculty
•Target Audience

To view the supplement, click the image above.

Photoprotection and Our Evolving Understanding of the Effects of Ultraviolet Light

• Introduction

• The Effects of UVA/UVB Radiation

• Sunscreens: A Historical Perspective

• Testing Standards and Labeling Issues

• Public Health Concerns

• Developing the Optimal Sunscreen

• UVA-Specific Photoprotectants

Summary

Faculty

Program ChairmanDarrell S. Rigel, MD
Clinical Professor
Deparment of Dermatology
New York University Medical Center
New York, New York
Consultant/Funding for Clinical Grants: Neutrogena Corporation

Diane S. Berson, MD
Assistant Professor
Department of Dermatology
Weill Medical College
Cornell University
New York, New York

Assistant Clinical Professor
Department of Dermatology
New York University School of Medicine
New York, New York
Consultant: Neutrogena Corporation.
She does not have any stock interests, equity interests, or patent-licensing arrangements that could be considered a conflict of interest for this supplement.

Robert J. Ceilly, MD
Clinical Professor
Department of Dermatology
University of Iowa
Des Moines, Iowa
Consultant: OrthoNeutrogena.
He does not have any stock interests, equity interests, or patent-licensing arrangements that could be considered a conflict of interest for this supplement.

Curtis A. Cole, PhD
Senior Director of Technology
Johnson & Johnson Consumer Products Company
Skillman, New Jersey
He is an employee of, directs funding for clinical grants, and holds stock from Johnson & Johnson.

Zoe Diana Draelos, MD
Clinical Associate Professor
Department of Dermatology
Wake Forest University School of Medicine
Winston-Salem, North Carolina
Consultant: Neutrogena Corporation.
She does not have any stock interests, equity interests, or patent-licensing arrangements that could be considered a conflict of interest for this supplement.

Target Audience

This supplement has been developed for dermatologists and other health care professionals who are concerned with issues involving photoprotection and who recommend sunscreen products to their patients.

Copyright © 2006 Elsevier Inc.

This educational supplement to Skin & Allergy News is supported by Neutrogena.
This supplement provides highlights of, and supplemental background information for, the roundtable panel discussion following the Stable Photoprotection Advisory Board Meeting, held October 28, 2005, in Atlanta, GA.

•Topic Highlights
•Faculty
•Target Audience

To view the supplement, click the image above.

Photoprotection and Our Evolving Understanding of the Effects of Ultraviolet Light

• Introduction

• The Effects of UVA/UVB Radiation

• Sunscreens: A Historical Perspective

• Testing Standards and Labeling Issues

• Public Health Concerns

• Developing the Optimal Sunscreen

• UVA-Specific Photoprotectants

Summary

Faculty

Program ChairmanDarrell S. Rigel, MD
Clinical Professor
Deparment of Dermatology
New York University Medical Center
New York, New York
Consultant/Funding for Clinical Grants: Neutrogena Corporation

Diane S. Berson, MD
Assistant Professor
Department of Dermatology
Weill Medical College
Cornell University
New York, New York

Assistant Clinical Professor
Department of Dermatology
New York University School of Medicine
New York, New York
Consultant: Neutrogena Corporation.
She does not have any stock interests, equity interests, or patent-licensing arrangements that could be considered a conflict of interest for this supplement.

Robert J. Ceilly, MD
Clinical Professor
Department of Dermatology
University of Iowa
Des Moines, Iowa
Consultant: OrthoNeutrogena.
He does not have any stock interests, equity interests, or patent-licensing arrangements that could be considered a conflict of interest for this supplement.

Curtis A. Cole, PhD
Senior Director of Technology
Johnson & Johnson Consumer Products Company
Skillman, New Jersey
He is an employee of, directs funding for clinical grants, and holds stock from Johnson & Johnson.

Zoe Diana Draelos, MD
Clinical Associate Professor
Department of Dermatology
Wake Forest University School of Medicine
Winston-Salem, North Carolina
Consultant: Neutrogena Corporation.
She does not have any stock interests, equity interests, or patent-licensing arrangements that could be considered a conflict of interest for this supplement.

Target Audience

This supplement has been developed for dermatologists and other health care professionals who are concerned with issues involving photoprotection and who recommend sunscreen products to their patients.

Copyright © 2006 Elsevier Inc.

A supplement to Skin & Allergy News.
This supplement was produced in affiliation with the 30th Hawaii Dermatology Seminar and the Cosmetic Dermatology Seminar.

•Topic Highlights
•Guest Editors

To view the supplement, click the image above.

• Evolving Clinical Roles of LED, Fillers, Botulinum Toxin

• Combining New and Traditional Techniques Provide Maximal Benefits to Patients

• Laser Technique Zaps Focal Areas of Excess Fat

• Is a Cosmetic Practice for You? Consider These Tips

• Ferulic Acid

• Examine Patient Motivation For Cosmetic Surgery

• Fillers: Beyond the Mythic 'Ideal'

• Injectable Silicone Called a Safe, Elegant Filler

• Pain-Relief Options Available For Cosmetic Procedures

Guest Editors

David J. Goldberg, MD, JD
Clinical Professor of Dermatology
Director, Laser Research and Mohs Surgery
Mount Sinai School of Medicine
Adjunct Professor of Law
Fordham Law School
New York, N.Y.
Director, Skin Laser & Surgery Specialists of New York/New Jersey
Hackensack, N.J.
Clinical Grants: Photo Therapeutics, Cynosure, Inc., Neocutis Swiss Technology, Inamed Corporation, Thermage, Inc., and Cutera Inc.; Consultant: BioForm Medical Inc., Lumenis Ltd., and Juva Medical Inc. He discusses the off-label use of Mentor Corporation, Inamed, and Juva products.

Christopher B. Zachary, FRCP
Chair and Clinical Professor
Department of Dermatology
Co-Director, Dermatologic Surgery and Laser Center
University of California at Irvine
Nothing to disclose.

Copyright © 2006 Elsevier Inc.

A supplement to Skin & Allergy News.
This supplement was produced in affiliation with the 30th Hawaii Dermatology Seminar and the Cosmetic Dermatology Seminar.

•Topic Highlights
•Guest Editors

To view the supplement, click the image above.

• Evolving Clinical Roles of LED, Fillers, Botulinum Toxin

• Combining New and Traditional Techniques Provide Maximal Benefits to Patients

• Laser Technique Zaps Focal Areas of Excess Fat

• Is a Cosmetic Practice for You? Consider These Tips

• Ferulic Acid

• Examine Patient Motivation For Cosmetic Surgery

• Fillers: Beyond the Mythic 'Ideal'

• Injectable Silicone Called a Safe, Elegant Filler

• Pain-Relief Options Available For Cosmetic Procedures

Guest Editors

David J. Goldberg, MD, JD
Clinical Professor of Dermatology
Director, Laser Research and Mohs Surgery
Mount Sinai School of Medicine
Adjunct Professor of Law
Fordham Law School
New York, N.Y.
Director, Skin Laser & Surgery Specialists of New York/New Jersey
Hackensack, N.J.
Clinical Grants: Photo Therapeutics, Cynosure, Inc., Neocutis Swiss Technology, Inamed Corporation, Thermage, Inc., and Cutera Inc.; Consultant: BioForm Medical Inc., Lumenis Ltd., and Juva Medical Inc. He discusses the off-label use of Mentor Corporation, Inamed, and Juva products.

Christopher B. Zachary, FRCP
Chair and Clinical Professor
Department of Dermatology
Co-Director, Dermatologic Surgery and Laser Center
University of California at Irvine
Nothing to disclose.

Copyright © 2006 Elsevier Inc.

A supplement to Skin & Allergy News.
This supplement was produced in affiliation with the 30th Hawaii Dermatology Seminar and the Cosmetic Dermatology Seminar.

•Topic Highlights
•Guest Editors

To view the supplement, click the image above.

• Evolving Clinical Roles of LED, Fillers, Botulinum Toxin

• Combining New and Traditional Techniques Provide Maximal Benefits to Patients

• Laser Technique Zaps Focal Areas of Excess Fat

• Is a Cosmetic Practice for You? Consider These Tips

• Ferulic Acid

• Examine Patient Motivation For Cosmetic Surgery

• Fillers: Beyond the Mythic 'Ideal'

• Injectable Silicone Called a Safe, Elegant Filler

• Pain-Relief Options Available For Cosmetic Procedures

Guest Editors

David J. Goldberg, MD, JD
Clinical Professor of Dermatology
Director, Laser Research and Mohs Surgery
Mount Sinai School of Medicine
Adjunct Professor of Law
Fordham Law School
New York, N.Y.
Director, Skin Laser & Surgery Specialists of New York/New Jersey
Hackensack, N.J.
Clinical Grants: Photo Therapeutics, Cynosure, Inc., Neocutis Swiss Technology, Inamed Corporation, Thermage, Inc., and Cutera Inc.; Consultant: BioForm Medical Inc., Lumenis Ltd., and Juva Medical Inc. He discusses the off-label use of Mentor Corporation, Inamed, and Juva products.

Christopher B. Zachary, FRCP
Chair and Clinical Professor
Department of Dermatology
Co-Director, Dermatologic Surgery and Laser Center
University of California at Irvine
Nothing to disclose.

Copyright © 2006 Elsevier Inc.

A supplement to Skin & Allergy News.
This supplement was produced in affiliation with Skin Disease Education Foundation's Cosmetic Dermatology Seminar and Skin & Allergy News.

•Topic Highlights
•Guest Editors
 

To view the supplement, click the image above.

• New Technology Adds Tools to Cosmetic Dermatology

• Extensive Experience Produces Array of Cosmetic Dermatology Devices

• A Refresher on Antioxidants

• How to Spot Neurosis in Cosmetic Candidates

• Peptides

• Cosmetic Practice: Follow Tips to Get Started

Guest Editors

David J. Goldberg, MD, JD
Clinical Professor of Dermatology
Director, Laser Research and Mohs Surgery
Mount Sinai School of Medicine
Adjunct Professor of Law
Fordham Law School
New York, N.Y.
Director, Skin Laser & Surgery Specialists of New York/New Jersey
Hackensack, N.J.
Consultant: Photo Therapeutics Limited and BioForm Medical, Inc. He discusses the off-label use of poly-L-lactic acid for the treatment of lipoatrophy in non-HIV-patients and the off-label use of calcium hydroxylapatite as a cosmetic filler agent.

Christopher B. Zachary, FRCP
Clinical Professor
Department of Dermatology
Co-Director, Dermatologic Surgery and Laser Center
University of California at San Francisco
Nothing to disclose.

Copyright © 2005 Elsevier Inc.

A supplement to Skin & Allergy News.
This supplement was produced in affiliation with Skin Disease Education Foundation's Cosmetic Dermatology Seminar and Skin & Allergy News.

•Topic Highlights
•Guest Editors
 

To view the supplement, click the image above.

• New Technology Adds Tools to Cosmetic Dermatology

• Extensive Experience Produces Array of Cosmetic Dermatology Devices

• A Refresher on Antioxidants

• How to Spot Neurosis in Cosmetic Candidates

• Peptides

• Cosmetic Practice: Follow Tips to Get Started

Guest Editors

David J. Goldberg, MD, JD
Clinical Professor of Dermatology
Director, Laser Research and Mohs Surgery
Mount Sinai School of Medicine
Adjunct Professor of Law
Fordham Law School
New York, N.Y.
Director, Skin Laser & Surgery Specialists of New York/New Jersey
Hackensack, N.J.
Consultant: Photo Therapeutics Limited and BioForm Medical, Inc. He discusses the off-label use of poly-L-lactic acid for the treatment of lipoatrophy in non-HIV-patients and the off-label use of calcium hydroxylapatite as a cosmetic filler agent.

Christopher B. Zachary, FRCP
Clinical Professor
Department of Dermatology
Co-Director, Dermatologic Surgery and Laser Center
University of California at San Francisco
Nothing to disclose.

Copyright © 2005 Elsevier Inc.

A supplement to Skin & Allergy News.
This supplement was produced in affiliation with Skin Disease Education Foundation's Cosmetic Dermatology Seminar and Skin & Allergy News.

•Topic Highlights
•Guest Editors
 

To view the supplement, click the image above.

• New Technology Adds Tools to Cosmetic Dermatology

• Extensive Experience Produces Array of Cosmetic Dermatology Devices

• A Refresher on Antioxidants

• How to Spot Neurosis in Cosmetic Candidates

• Peptides

• Cosmetic Practice: Follow Tips to Get Started

Guest Editors

David J. Goldberg, MD, JD
Clinical Professor of Dermatology
Director, Laser Research and Mohs Surgery
Mount Sinai School of Medicine
Adjunct Professor of Law
Fordham Law School
New York, N.Y.
Director, Skin Laser & Surgery Specialists of New York/New Jersey
Hackensack, N.J.
Consultant: Photo Therapeutics Limited and BioForm Medical, Inc. He discusses the off-label use of poly-L-lactic acid for the treatment of lipoatrophy in non-HIV-patients and the off-label use of calcium hydroxylapatite as a cosmetic filler agent.

Christopher B. Zachary, FRCP
Clinical Professor
Department of Dermatology
Co-Director, Dermatologic Surgery and Laser Center
University of California at San Francisco
Nothing to disclose.

Copyright © 2005 Elsevier Inc.

A supplement to Skin & Allergy News.
Supported by an educational grant from Stiefel.
The articles in this supplement are based on presentations made during the Skin Disease Education Foundation's 29th Annual Hawaii Dermatology Seminar, on March 18-24, 2005, in Maui, Hawaii.

•Topics
•Faculty/Faculty Disclosure Statement
•Target Audience

To view the supplement, click the image above.

• The Importance of Vehicle in Acne Therapy
• Acne Management: Treatment Strategies and Challenges
• Cosmetic Management of Patients with Acne Vulgaris and Acne Rosacea
• The Resurgence of Benzoyl Peroxide in Acne Therapy
• New Treatment Options for Acne Rosacea

Faculty/Faculty Disclosure Statement

Emil A. Tanghetti, MD, Chair
Clinical Professor of Dermatology
Department of Dermatology
University of California, Davis
Medical Director
Center for Dermatology and Laser Surgery
Sacramento, Calif.
Consultant: Stiefel Laboratories, Inc.

Diane S. Berson, MD
Assistant Professor of Dermatology
Weill Medical College of Cornell University
New York, NY
Advisory Boards: Allergan, Inc., Connectics Corporation, Dermik Laboratories, Galderma International, and Medicis Pharmaceuticals Corporation.

Michael H. Gold, MD
Gold Skin Care Center
Nashville, Tenn.
No financial relationships to disclose.

Mary P. Lupo, MD
Clinical Professor of Dermatology
Tulane University Medical School
New Orleans, LA
Consultant: Stiefel Laboratories, Inc., Allergan and Dermik

Barry A. Solomon, MD, JD
Assistant Clinical Professor of Dermatology
Kings County Hospital Center
SUNY Health Science Center
Brooklyn, NY
Consultant: Stiefel Laboratories, Inc. He also discusses the investigational use of clindamycin 1% and benzoyl peroxide 5% for the treatment of acne rosacea.

Target Audience

This activity has been designed for healthcare professionals, including dermatologists and pediatricians, who are involved in the treatment of patients with acne vulgaris and acne rosacea.

Copyright © 2005 by International Medical News Group

A supplement to Skin & Allergy News.
Supported by an educational grant from Stiefel.
The articles in this supplement are based on presentations made during the Skin Disease Education Foundation's 29th Annual Hawaii Dermatology Seminar, on March 18-24, 2005, in Maui, Hawaii.

•Topics
•Faculty/Faculty Disclosure Statement
•Target Audience

To view the supplement, click the image above.

• The Importance of Vehicle in Acne Therapy
• Acne Management: Treatment Strategies and Challenges
• Cosmetic Management of Patients with Acne Vulgaris and Acne Rosacea
• The Resurgence of Benzoyl Peroxide in Acne Therapy
• New Treatment Options for Acne Rosacea

Faculty/Faculty Disclosure Statement

Emil A. Tanghetti, MD, Chair
Clinical Professor of Dermatology
Department of Dermatology
University of California, Davis
Medical Director
Center for Dermatology and Laser Surgery
Sacramento, Calif.
Consultant: Stiefel Laboratories, Inc.

Diane S. Berson, MD
Assistant Professor of Dermatology
Weill Medical College of Cornell University
New York, NY
Advisory Boards: Allergan, Inc., Connectics Corporation, Dermik Laboratories, Galderma International, and Medicis Pharmaceuticals Corporation.

Michael H. Gold, MD
Gold Skin Care Center
Nashville, Tenn.
No financial relationships to disclose.

Mary P. Lupo, MD
Clinical Professor of Dermatology
Tulane University Medical School
New Orleans, LA
Consultant: Stiefel Laboratories, Inc., Allergan and Dermik

Barry A. Solomon, MD, JD
Assistant Clinical Professor of Dermatology
Kings County Hospital Center
SUNY Health Science Center
Brooklyn, NY
Consultant: Stiefel Laboratories, Inc. He also discusses the investigational use of clindamycin 1% and benzoyl peroxide 5% for the treatment of acne rosacea.

Target Audience

This activity has been designed for healthcare professionals, including dermatologists and pediatricians, who are involved in the treatment of patients with acne vulgaris and acne rosacea.

Copyright © 2005 by International Medical News Group

A supplement to Skin & Allergy News.
Supported by an educational grant from Stiefel.
The articles in this supplement are based on presentations made during the Skin Disease Education Foundation's 29th Annual Hawaii Dermatology Seminar, on March 18-24, 2005, in Maui, Hawaii.

•Topics
•Faculty/Faculty Disclosure Statement
•Target Audience

To view the supplement, click the image above.

• The Importance of Vehicle in Acne Therapy
• Acne Management: Treatment Strategies and Challenges
• Cosmetic Management of Patients with Acne Vulgaris and Acne Rosacea
• The Resurgence of Benzoyl Peroxide in Acne Therapy
• New Treatment Options for Acne Rosacea

Faculty/Faculty Disclosure Statement

Emil A. Tanghetti, MD, Chair
Clinical Professor of Dermatology
Department of Dermatology
University of California, Davis
Medical Director
Center for Dermatology and Laser Surgery
Sacramento, Calif.
Consultant: Stiefel Laboratories, Inc.

Diane S. Berson, MD
Assistant Professor of Dermatology
Weill Medical College of Cornell University
New York, NY
Advisory Boards: Allergan, Inc., Connectics Corporation, Dermik Laboratories, Galderma International, and Medicis Pharmaceuticals Corporation.

Michael H. Gold, MD
Gold Skin Care Center
Nashville, Tenn.
No financial relationships to disclose.

Mary P. Lupo, MD
Clinical Professor of Dermatology
Tulane University Medical School
New Orleans, LA
Consultant: Stiefel Laboratories, Inc., Allergan and Dermik

Barry A. Solomon, MD, JD
Assistant Clinical Professor of Dermatology
Kings County Hospital Center
SUNY Health Science Center
Brooklyn, NY
Consultant: Stiefel Laboratories, Inc. He also discusses the investigational use of clindamycin 1% and benzoyl peroxide 5% for the treatment of acne rosacea.

Target Audience

This activity has been designed for healthcare professionals, including dermatologists and pediatricians, who are involved in the treatment of patients with acne vulgaris and acne rosacea.

Copyright © 2005 by International Medical News Group

A supplement to Skin & Allergy News.
Supported by an educational grant from Stiefel.
The articles in this supplement are based on a faculty interview and reviews of selected posters that were presented at a medical conference held February 18-22, 2005, in New Orleans.

•Contents
•Faculty/Faculty Disclosure Statement

To view the supplement, click the image above.

• Combination Tazarotene and Clindamycin/Benzoyl Peroxide
• Use of Clindamycin 1%/Benzoyl Peroxide 5% Gel Alone and in Combination for Acne Vulgaris
• Patient Preference for Clindamycin/Benzoyl Peroxide Gel Formulations
• Quantitative Assessment of the Application and Consumption of Topical Acne Medication by Patients
• Sulfacetamide/Sulfur Combination With Sunscreen for Rosacea

Faculty/Faculty Disclosure Statement

James Q. Del Rosso, DO, FAOCD
University of Nevada
School of Medicine
Las Vegas
Received funding for clinical grants: Galderma S.A., Intendis Inc., Medicis Pharmaceutical Corporations, Stiefel Laboratories, Inc.
Consultant: Galderma, Intendis, Stiefel.
He discusses the use of metronidazole and azelaic acid as a once-a-day treatment for rosacea as opposed to twice daily.

Copyright © 2005 by International Medical News Group

A supplement to Skin & Allergy News.
Supported by an educational grant from Stiefel.
The articles in this supplement are based on a faculty interview and reviews of selected posters that were presented at a medical conference held February 18-22, 2005, in New Orleans.

•Contents
•Faculty/Faculty Disclosure Statement

To view the supplement, click the image above.

• Combination Tazarotene and Clindamycin/Benzoyl Peroxide
• Use of Clindamycin 1%/Benzoyl Peroxide 5% Gel Alone and in Combination for Acne Vulgaris
• Patient Preference for Clindamycin/Benzoyl Peroxide Gel Formulations
• Quantitative Assessment of the Application and Consumption of Topical Acne Medication by Patients
• Sulfacetamide/Sulfur Combination With Sunscreen for Rosacea

Faculty/Faculty Disclosure Statement

James Q. Del Rosso, DO, FAOCD
University of Nevada
School of Medicine
Las Vegas
Received funding for clinical grants: Galderma S.A., Intendis Inc., Medicis Pharmaceutical Corporations, Stiefel Laboratories, Inc.
Consultant: Galderma, Intendis, Stiefel.
He discusses the use of metronidazole and azelaic acid as a once-a-day treatment for rosacea as opposed to twice daily.

Copyright © 2005 by International Medical News Group

A supplement to Skin & Allergy News.
Supported by an educational grant from Stiefel.
The articles in this supplement are based on a faculty interview and reviews of selected posters that were presented at a medical conference held February 18-22, 2005, in New Orleans.

•Contents
•Faculty/Faculty Disclosure Statement

To view the supplement, click the image above.

• Combination Tazarotene and Clindamycin/Benzoyl Peroxide
• Use of Clindamycin 1%/Benzoyl Peroxide 5% Gel Alone and in Combination for Acne Vulgaris
• Patient Preference for Clindamycin/Benzoyl Peroxide Gel Formulations
• Quantitative Assessment of the Application and Consumption of Topical Acne Medication by Patients
• Sulfacetamide/Sulfur Combination With Sunscreen for Rosacea

Faculty/Faculty Disclosure Statement

James Q. Del Rosso, DO, FAOCD
University of Nevada
School of Medicine
Las Vegas
Received funding for clinical grants: Galderma S.A., Intendis Inc., Medicis Pharmaceutical Corporations, Stiefel Laboratories, Inc.
Consultant: Galderma, Intendis, Stiefel.
He discusses the use of metronidazole and azelaic acid as a once-a-day treatment for rosacea as opposed to twice daily.

Copyright © 2005 by International Medical News Group